R Paul Edick

Affiliations

  • See Remarks at Xeris Biopharma Holdings Inc. (XERS), 2024-01-31
  • Chief Executive Officer at Xeris Pharmaceuticals Inc (XERS), 2021-10-05
  • Director at Milestone Pharmaceuticals Inc. (MIST), 2020-06-08
  • Director at Iterum Therapeutics Plc (ITRM), 2019-05-29
  • Director at Pdl Biopharma Inc. (PDLI), 2018-06-12
  • Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
  • Director at Neos Therapeutics Inc. (NEOS), 2017-07-05
  • Director at Newlink Genetics Corp ((NLNK)), 2017-05-16
  • Chief Executive Officer at Durata Therapeutics Inc. (DRTX), 2014-11-18
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XERS $2.38 10,000 Officer, Director 2,288,064 2023-08-09 Filing
XERS $1.45 20,000 Officer, Director 1,528,064 2022-12-13 Filing
XERS $1.40 100,000 Officer, Director 1,508,064 2022-05-12 Filing
XERS $2.28 20,000 Officer, Director 33,430 2021-11-15 Filing
XERS $2.08 200,000 Officer, Director 808,064 2021-11-11 Filing